Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Sturek JM, Thomas TA, Gorham JD, Sheppard CA, Raymond AH, Petros De Guex K, Harrington WB, Barros AJ, Madden GR, Alkabab YM, Lu DY, Liu Q, Poulter MD, Mathers AJ, Thakur A, Schalk DL, Kubicka EM, Lum LG, Heysell SK.
Sturek JM, et al. Among authors: petros de guex k.
Microbiol Spectr. 2022 Feb 23;10(1):e0256021. doi: 10.1128/spectrum.02560-21. Epub 2022 Feb 23.
Microbiol Spectr. 2022.
PMID: 35196802
Free PMC article.
Clinical Trial.